Items where authors include "Riches, K"

Article

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Niemi, MEK, Karjalainen, J, Liao, RG et al. (3763 more authors) (2021) Mapping the human genetic architecture of COVID-19. Nature, 600 (7889). pp. 472-477. ISSN 0028-0836

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

Aziz, A, Haywood, NJ orcid.org/0000-0002-8762-7257, Cordell, PA et al. (11 more authors) (2018) Insulinlike Growth Factor-Binding Protein-1 Improves Vascular Endothelial Repair in Male Mice in the Setting of Insulin Resistance. Endocrinology, 159 (2). pp. 696-709. ISSN 0013-7227

Riches, K, Clark, E, Helliwell, RJ et al. (6 more authors) (2018) Progressive Development of Aberrant Smooth Muscle Cell Phenotype in Abdominal Aortic Aneurysm Disease. Journal of Vascular Research, 55 (1). pp. 35-46. ISSN 1018-1172

Riches, K, Huntriss, J, Keeble, CM orcid.org/0000-0003-1633-8842 et al. (4 more authors) (2017) Mapping the methylation status of the miR-145 promoter in saphenous vein smooth muscle cells from individuals with type 2 diabetes. Diabetes and Vascular Disease Research, 14 (2). pp. 122-129. ISSN 1479-1641

Roberts, AC, Gohil, J, Hudson, L et al. (8 more authors) (2015) Aberrant phenotype in human endothelial cells of diabetic origin: Implications for saphenous vein graft failure? Journal of Diabetes Research, 2015. 409432. ISSN 2314-6745

Riches, K, Alshanwani, AR, Warburton, P et al. (5 more authors) (2014) Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function. Journal of Molecular and Cellular Cardiology, 74. pp. 240-250. ISSN 0022-2828

Sedgwick, B, Riches, K, Bageghni, SA et al. (3 more authors) (2014) Investigating inherent functional differences between human cardiac fibroblasts cultured from nondiabetic and Type 2 diabetic donors. Cardiovascular Pathology, 23 (4). 204 - 210. ISSN 1054-8807

Riches, K, Warburton, P, O'Regan, DJ et al. (2 more authors) (2014) Type 2 diabetes impairs venous, but not arterial smooth muscle cell function: possible role of differential RhoA activity. Cardiovascular Revascularization Medicine, 15 (3). 141 - 148. ISSN 1878-0938

Riches, K, Angelini, TG, Mudhar, GS et al. (8 more authors) (2013) Exploring smooth muscle phenotype and function in a bioreactor model of abdominal aortic aneurysm. Journal of Translational Medicine, 11 (1). 208. ISSN 1479-5876

Riches, K, Franklin, L, Maqbool, A et al. (10 more authors) (2013) Apolipoprotein(a) acts as a chemorepellent to human vascular smooth muscle cells via integrin αVβ3 and RhoA/ROCK-mediated mechanisms. The International Journal of Biochemistry and Cell Biology, 45 (8). 1776 - 1783. ISSN 1357-2725

Porter, KE and Riches, K (2013) The vascular smooth muscle cell: A therapeutic target in type 2 diabetes? Clinical Science, 125 (4). 167 - 182. ISSN 0143-5221

Riches, K and Porter, KE (2012) Lipoprotein(a): cellular effects and molecular mechanisms. Cholesterol, 2012. 923289. ISSN 2090-1283

Cheong, A, Li, J, Sukumar, P orcid.org/0000-0002-3294-989X et al. (7 more authors) (2011) Potent suppression of vascular smooth muscle cell migration and human neointimal hyperplasia by KV1.3 channel blockers. Cardiovascular Research, 89 (2). pp. 282-289. ISSN 0008-6363

Mughal, RS, Scragg, JL, Lister, P et al. (6 more authors) (2010) Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein. Diabetologia, 53 (8). pp. 1761-1771. ISSN 0012-186X